PCI BIOTECH HOLDING ASA

0379 OSLO

Finances

Return on Equity

−95,98 %

Current Ratio

10,91

Debt-to-Equity Ratio

0,01

Key figures (NOK)	2022	2021	2020	2019
Revenue	4 750 000	6 273 000	7 368 000	9 392 000
Net Income	−55 095 000	−88 391 000	−72 239 000	−88 746 000
Total Assets	63 481 000	135 978 000	209 122 000	282 032 000
Total Equity	57 402 000	113 793 000	189 244 000	254 829 000

Income (NOK)	2022	2021	2020	2019
Revenue	4 750 000	6 273 000	7 368 000	9 392 000
Expenditure	61 197 000	92 302 000	89 488 000	98 195 000
Operating Profit	−56 447 000	−86 029 000	−82 120 000	−88 803 000
Financial Income	1 711 000	789 000	10 796 000	2 737 000
Financial Costs	359 000	3 151 000	915 000	2 680 000
Financial Balance	1 352 000	−2 362 000	9 881 000	57 000
Earnings Before Tax	−55 095 000	−88 391 000	−72 239 000	−88 746 000
Tax	0	0	0	0
Net Income	−55 095 000	−88 391 000	−72 239 000	−88 746 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	723 000	7 660 000	7 993 000	6 283 000
Total Current Assets	62 758 000	128 318 000	201 129 000	275 749 000
Total Assets	63 481 000	135 978 000	209 122 000	282 032 000
Total Retained Equity	0	−448 650 000	−373 199 000	−307 297 000
Total Equity	57 402 000	113 793 000	189 244 000	254 829 000
Total Long-Term Debt	327 000	1 277 000	32 000	2 576 000
Total Current Debt	5 753 000	20 910 000	19 848 000	24 627 000
Total Equity and Debt	63 482 000	135 980 000	209 124 000	282 032 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	4 750 000	6 273 000	7 368 000	9 392 000
Revenue	4 750 000	6 273 000	7 368 000	9 392 000
Cost of Goods Sold	0	0	0	0
Salary Costs	0	0	0	0
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	61 197 000	92 302 000	89 488 000	98 195 000
Operating Profit	−56 447 000	−86 029 000	−82 120 000	−88 803 000
Financial Income	1 711 000	789 000	10 796 000	2 737 000
Financial Costs	359 000	3 151 000	915 000	2 680 000
Financial Balance	1 352 000	−2 362 000	9 881 000	57 000
Dividends	0	0	0	0
Net Income	−55 095 000	−88 391 000	−72 239 000	−88 746 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	723 000	7 660 000	7 993 000	6 283 000
Total Tangible Assets	723 000	7 660 000	7 993 000	6 283 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	723 000	7 660 000	7 993 000	6 283 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	56 596 000	116 118 000	187 967 000	261 103 000
Total Current Assets	62 758 000	128 318 000	201 129 000	275 749 000
Total Assets	63 481 000	135 978 000	209 122 000	282 032 000
Total Equity	57 402 000	113 793 000	189 244 000	254 829 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	327 000	1 277 000	32 000	2 576 000
Creditors	0	0	5 191 000	8 601 000
Unpaid Taxes	0	0	2 107 000	4 684 000
Dividends	0	0	0	0
Other Current Debt	5 753 000	20 910 000	12 550 000	11 342 000
Total Current Debt	5 753 000	20 910 000	19 848 000	24 627 000
Total Equity and Debt	63 482 000	135 980 000	209 124 000	282 032 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−95,98 %	−77,68 %	−38,17 %	−34,83 %
Debt-to-Equity Ratio	0,01	0,01	0	0,01
Operating Profit Margin	−1 188,36 %	−1 371,42 %	−1 114,55 %	−945,52 %
Current Ratio	10,91	6,14	10,13	11,2
Quick Ratio	10,91	6,14	10,13	11,2
Equity Ratio	0,9	0,84	0,9	0,9
Gross Profit Margin	100 %	100 %	100 %	100 %